Savannah Chantae Doughty, APRN

Savannah Doughty practices at Olympia Neurological Institute in Mcalester, Oklahoma.

Savannah Doughty's NPI, 1114573250, was assigned on August 14, 2019. Savannah Doughty holds Oklahoma license 101472.

Savannah Doughty's primary practice is Olympia Neurological Institute, at 1030 E Washington Ave, Mcalester, OK 74501. The practice phone is (918) 401-1002.

Savannah Doughty's primary practice is Olympia Neurological Institute in Mcalester, Oklahoma. Savannah Doughty is also affiliated with McAlester Regional Health Center. The medical group on file is Olympia Neurological Institute.

Dmand AI tracks the electronic health record (EHR) system at each site where Savannah Doughty practices, 2 sites in all. Vendor and product names are available with a free account.

Family is Savannah Doughty's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Savannah Doughty is licensed in Oklahoma.

CMS counts 152 Medicare patients who saw Savannah Doughty in 2024. The largest group is under 65, with 63 patients. 75% of them have high blood pressure, and 68% have arthritis. 41% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Savannah Doughty's median patient age at 63, with 59% women.

In 2024, Savannah Doughty wrote 1,323 Medicare Part D claims for 233 patients. 93% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Savannah Doughty for performance year 2024, reported as part of a group. Savannah Doughty accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Savannah Doughty as offering telehealth.

CMS Open Payments shows 5 general payments to Savannah Doughty from 1 drug or device company in 2025. Food and beverage make up the largest share, 90% of the total. ANI Pharmaceuticals, Inc. paid the most, $71.